AC Immunes Active Immunotherapy Shows Antibody Responses In Early Parkinsons Patients
ACIU Stock | USD 2.68 0.02 0.74% |
Slightly above 61% of AC Immune's investor base is looking to short. The analysis of the overall investor sentiment regarding AC Immune suggests that many traders are alarmed. AC Immune's investing sentiment can be driven by a variety of factors including economic data, AC Immune's earnings reports, geopolitical events, and overall market trends.
ACIU |
AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinsons disease.
Read at benzinga.com
AC Immune Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards AC Immune can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
AC Immune Fundamental Analysis
We analyze AC Immune's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of AC Immune using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of AC Immune based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Per Share
Cash Per Share Comparative Analysis
AC Immune is currently under evaluation in cash per share category among its peers. Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
AC Immune Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with AC Immune stock to make a market-neutral strategy. Peer analysis of AC Immune could also be used in its relative valuation, which is a method of valuing AC Immune by comparing valuation metrics with similar companies.
Peers
AC Immune Related Equities
FDMT | 4D Molecular | 9.17 | ||||
SYBX | Synlogic | 3.65 | ||||
OPT | Opthea | 3.41 | ||||
STOK | Stoke Therapeutics | 3.36 | ||||
PHVS | Pharvaris | 2.95 | ||||
RGNX | Regenxbio | 2.83 | ||||
IVVD | Invivyd | 2.33 | ||||
BDTX | Black Diamond | 1.37 | ||||
ABEO | Abeona Therapeutics | 1.24 | ||||
PMVP | Pmv Pharmaceuticals | 0.67 | ||||
MNOV | MediciNova | 0.46 | ||||
ACRV | Acrivon Therapeutics, | 0.30 | ||||
ANTX | AN2 Therapeutics | 0.79 | ||||
AVTE | Aerovate Therapeutics | 1.17 | ||||
ANEB | Anebulo Pharmaceuticals | 10.81 | ||||
PEPG | PepGen | 11.25 |
Additional Tools for ACIU Stock Analysis
When running AC Immune's price analysis, check to measure AC Immune's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AC Immune is operating at the current time. Most of AC Immune's value examination focuses on studying past and present price action to predict the probability of AC Immune's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AC Immune's price. Additionally, you may evaluate how the addition of AC Immune to your portfolios can decrease your overall portfolio volatility.